Xylem Analyst Price Targets - Benzinga

SPY—QQQ707.87−0.27%BTC/USD—DIA518.00−0.21%GLD381.40−0.16%TLT80.06+0.01%

Xylem Inc

XYLNYSE

Trade with Public

Trade with Public

$104.05

0.680.66%

Last update: Oct 16, 4:07 PM

$104.10

0.730.71%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Xylem Analyst Price Targets - Benzinga

Xylem Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xylem (XYL).

Price Target Range — 13 Quarters

Analyst Consensus — 15 Analysts

12Buy

3Hold

Consensus RatingBuy# Analysts15Avg. Consensus PT$146Upside to Avg. PT+40.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	Mizuho	Brett Linzey	PT Cut	Neutral	$130→$110
Oct 14, 2026	Oppenheimer	Bryan Blair	PT Cut	Outperform	$158→$150
Oct 14, 2026	RBC Capital	Jeffrey Reive	PT Cut	Outperform	$164→$135
Oct 13, 2026	Barclays	William Grippin	PT Cut	Overweight	$159→$139
Oct 12, 2026	Citigroup	Andrew Kaplowitz	PT Cut	Buy	$172→$148
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$138→$112
Sep 15, 2026	Wolfe Research	Nigel Coe	Assumes	Peer Perform	—
Aug 24, 2026	Jefferies	Stephen Volkmann	PT Raise	Buy	$145→$150
Aug 13, 2026	UBS	Joshua Spector	PT Raise	Neutral	$135→$138
Jul 30, 2026	UBS	Joshua Spector	PT Raise	Neutral	$129→$135
Jul 29, 2026	Stifel	Nathan Jones	PT Raise	Buy	$157→$160
Jul 29, 2026	Mizuho	Brett Linzey	PT Raise	Neutral	$124→$130
Jul 29, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$159→$164
Jul 29, 2026	Barclays	William Grippin	PT Raise	Overweight	$154→$159
Jul 29, 2026	Baird	Michael Halloran	PT Raise	Outperform	$163→$165
Jul 20, 2026	Stifel	Nathan Jones	PT Cut	Buy	$159→$157
Jul 16, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$157→$159
Jun 25, 2026	Jefferies	Stephen Volkmann	Upgrade	Hold→Buy	$130→$140
Apr 29, 2026	UBS	Joshua Spector	PT Raise	Neutral	$132→$133
Apr 29, 2026	Citigroup	Andrew Kaplowitz	PT Cut	Buy	$174→$168

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Mizuho Maintains Neutral on Xylem, Lowers Price Target to $110

Mizuho analyst Brett Linzey maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $130 to $110.

Benzinga Newsdesk

PRO
Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150

Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135

RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Xylem, Lowers Price Target to $139

Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and lowers the price target from $159 to $139.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Xylem, Lowers Price Target to $148

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $172 to $148.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Xylem, Lowers Price Target to $112

UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $138 to $112.

Benzinga Newsdesk